These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 25196155)

  • 21. Neuroprotection in acute ischaemic stroke. II: Clinical potential.
    Davis M; Barer D
    Vasc Med; 1999; 4(3):149-63. PubMed ID: 10512595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke.
    Smith CJ; Denes A; Tyrrell PJ; Di Napoli M
    Expert Opin Investig Drugs; 2015 May; 24(5):623-43. PubMed ID: 25727670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin use before and after acute ischemic stroke onset improves neurological outcome.
    Salat D; Ribosa R; Garcia-Bonilla L; Montaner J
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1219-30. PubMed ID: 19814665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
    Bordet R; Ouk T; Petrault O; Gelé P; Gautier S; Laprais M; Deplanque D; Duriez P; Staels B; Fruchart JC; Bastide M
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1341-6. PubMed ID: 17073815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current and future aspects of intravenous thrombolysis for acute stroke].
    Toyoda K
    Brain Nerve; 2013 Jul; 65(7):753-60. PubMed ID: 23832978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia.
    Sutherland BA; Papadakis M; Chen RL; Buchan AM
    J Physiol; 2011 Sep; 589(17):4105-14. PubMed ID: 21708904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
    De Keyser J; Sulter G; Luiten PG
    Trends Neurosci; 1999 Dec; 22(12):535-40. PubMed ID: 10542428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection in acute ischaemic stroke. Current status and future potential.
    Lutsep HL; Clark WM
    Drugs R D; 1999 Jan; 1(1):3-8. PubMed ID: 10565968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
    Vaughan CJ; Delanty N; Basson CT
    CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of cerebral ischemia.
    Ducruet AF; Grobelny BT; Zacharia BE; Hickman ZL; Yeh ML; Connolly ES
    Expert Opin Pharmacother; 2009 Aug; 10(12):1895-906. PubMed ID: 19514865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research.
    Reis C; Akyol O; Ho WM; Araujo C; Huang L; Applegate R; Zhang JH
    Biomed Res Int; 2017; 2017():4863079. PubMed ID: 28286764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status and perspectives of neuroprotection in ischemic stroke treatment.
    Martínez-Vila E; Sieira PI
    Cerebrovasc Dis; 2001; 11 Suppl 1():60-70. PubMed ID: 11244202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The penumbra, therapeutic time window and acute ischaemic stroke.
    Fisher M; Takano K
    Baillieres Clin Neurol; 1995 Aug; 4(2):279-95. PubMed ID: 7496621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
    Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
    Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced neuroprotection for brain ischemia: an alternative approach to minimize stroke damage.
    Ayuso MI; Montaner J
    Expert Opin Investig Drugs; 2015; 24(9):1137-42. PubMed ID: 26138255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of progesterone treatment for ischaemic stroke.
    Gibson CL; Bath PM
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):487-91. PubMed ID: 26661235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.
    Liu R; Yuan H; Yuan F; Yang SH
    Neurol Res; 2012 May; 34(4):331-7. PubMed ID: 22643076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.